Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process and pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products and services, and potent solid oral drug products. PPS also offers development and manufacturing services for biologics including vaccines and gene therapies, made possible through Piramal Pharma Limited’s associate company, Yapan Bio Private Limited.
From discovery to intermediates, APIs & drug products, a CDMO needs expertise across multiple elements of the pharma process to deliver an integrated experience
Released By Piramal Pharma Solutions
This will support the advancement of a novel ophthalmic therapeutic through clinical development and onto the market.
By: Rachel Klemovitch
The companies partner on antibody drug conjugates, drug substance, and drug product manufacturing services.
Rod Ketner on Serán BioScience’s science-first culture and what biotechs should look for in a CDMO.
Released By Serán Bioscience
Investment enables GL CHEMTEC to provide preclinical and first-in-human offerings.
Jeff Speicher of PLD Pharma Services on market shifts, customer trends, and the complexities of onboarding at CPHI Americas 2025.
Released By PLD Pharma Services
Vice President of Quality and Regulatory discusses the industry's expectations of CDMOs in today’s market and advancing to support evolving needs.
Released By Grand River Aseptic Manufacturing
Robert will be responsible for creating commercial and organizational synergies between the API Solutions and CDMO operations.
By: Charlie Sternberg
Released By Mikart
Confirms the site’s full compliance with current Good Manufacturing Practices (cGMP).
Agrees to acquire two biologics manufacturing facilities from Agenus Inc. in California.
The IDMO Smart Factory will enable scalable and cost-effective cell therapy manufacturing.
CEO Owen Murray on driving innovation with high science and high service.
By: Tim Wright
Industry experts weigh in on current trends, challenges, and the future of the cell and gene therapy CDMO market.
How specialized expertise, advanced infrastructure, and strategic partnerships are enabling the next generation of cell-based treatments.
By: Nimrod Bar Zvi
How can early decisions in cell and gene therapy clinical development impact downstream progress toward commercialization and patient access?
By: Dr. Diego Correa, Erin Finot
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
